Full text
PDF









Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- CULLIGAN J. J., GUNKEL R. D., JACOBS L., COOK M. K. Diagnosis and treatment of toxoplasmic uveitis. Trans Am Acad Ophthalmol Otolaryngol. 1954 Nov-Dec;58(6):867–884. [PubMed] [Google Scholar]
- DAVENPORT R. C. Uveitis. Proc R Soc Med. 1956 Jan;49(1):19–23. [PMC free article] [PubMed] [Google Scholar]
- DUKE-ELDER S., ASHTON N., BRIHAYEVAN GEERTRUYDEN M. Toxoplasmosis in the adult. Br J Ophthalmol. 1953 Jun;37(6):321–329. doi: 10.1136/bjo.37.6.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HOGAN M. J. Ocular toxoplasmosis; clinical and laboratory diagnosis; evaluation of immunologic tests; treatment. AMA Arch Ophthalmol. 1956 Mar;55(3):333–345. [PubMed] [Google Scholar]
- SMITH C., PERKINS E. S. The preliminary results of the treatment of uveitis with daraprim. Proc R Soc Med. 1956 Jan;49(1):24–26. [PMC free article] [PubMed] [Google Scholar]
- SUMMERS W. A. The chemotherapeutic efficacy of 2,4-diamino-5-p-chlorophenyl-6-ethylpyrimidine (daraprim) in experimental toxoplasmosis. Am J Trop Med Hyg. 1953 Nov;2(6):1037–1044. doi: 10.4269/ajtmh.1953.2.1037. [DOI] [PubMed] [Google Scholar]
- Sabin A. B., Feldman H. A. Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasite (Toxoplasma). Science. 1948 Dec 10;108(2815):660–663. doi: 10.1126/science.108.2815.660. [DOI] [PubMed] [Google Scholar]
- TREVINO A., VARELA G., PALENCIA L. Terapéutica de la toxoplasmosis experimental del raton blanco con hidroxicloroquina (win 1258-2), 5-p-clorofenil-2, 4-diamino-6-etil pirimidina (pirimetamina o daraprim) y fumagilina (fumidil). Rev Inst Salubr Enferm Trop. 1953 Dec;13(4):339–341. [PubMed] [Google Scholar]
- WILDER H. C. Toxoplasma chorioretinitis in adults. AMA Arch Ophthalmol. 1952 Aug;48(2):127–136. doi: 10.1001/archopht.1952.00920010132001. [DOI] [PubMed] [Google Scholar]
- WOODS A. C., JACOBS L., WOOD R. M., COOK M. K. A study of the role of toxoplasmosis in adult chorioretinitis. Trans Am Acad Ophthalmol Otolaryngol. 1954 Mar-Apr;58(2):172–200. [PubMed] [Google Scholar]